Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA accepts Cell Therapeutics' resubmission of pixantrone NDA as complete

Dec. 7, 2011

Oncolytics Biotech reports on Reolysin in pancreatic cancer

Dec. 7, 2011

Belgian university discloses novel Amaryllidaceae isocarbostyryl derivatives for cancer

Dec. 7, 2011

Infinity Pharmaceuticals patents novel fatty acid synthase inhibitors

Dec. 7, 2011

U3-1287 combinations assessed in lung and pharynx cancer

Dec. 7, 2011

Human monoclonal antibodies show anticancer potential in preclinical and clinical settings

Dec. 7, 2011

Cell Therapeutics provides update on MAA for Pixuvri

Dec. 5, 2011

Researchers at GlaxoSmithKline disclose new EZH2 inhibitors

Dec. 5, 2011

Sentinel Oncology synthesizes novel Chk1 inhibitors

Dec. 5, 2011

Nerviano Medical Sciences presents preclinical findings on NMS-P948

Dec. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...